# iShares Ageing Population UCITS ETF (AGES)

**Page:** https://fundology.uk/fund/ages · ISIN IE00BYZK4669

## At a glance

> Capital at risk. Past performance is not a guide to future returns. The value of investments can fall as well as rise.

As of 13/11/2026, AGES (iShares Ageing Population UCITS ETF, ISIN IE00BYZK4669) closed at £8.02 on the London Stock Exchange. Its ongoing charge is 0.40% a year (about £40 on £10,000). Over the five years to 13/11/2026 its total return was +40.4%, or +9.6% after UK CPIH inflation.

## Summary

iShares Ageing Population UCITS ETF is an exchange-traded fund (ETF) from iShares, launched in 2016. It tracks the STOXX Global Ageing Population Index - USD. You buy and sell it through a share-dealing account or platform during stock-market hours, like a share. Its ongoing charge is 0.4% a year — about £40 a year on every £10,000 invested, taken from the fund's value rather than billed to you. Income from its investments is reinvested inside the fund, so it shows up as a rising price rather than cash paid to you.

Latest close: **£8.02** (13/11/2026).

## Key facts

| Fact | Value |
|---|---|
| Ticker (LSE) | AGES |
| ISIN | IE00BYZK4669 |
| Also listed as | AGED (London Stock Exchange, US dollars), 2B77 (Xetra, euros) |
| Category | Healthcare |
| Type | ETF |
| Provider | iShares |
| Tracks | STOXX Global Ageing Population Index - USD |
| Income | Accumulating |
| Ongoing charge | 0.40% a year (£40 per £10,000) |
| Fund size | £677m |
| Launched | 2016 |
| Domicile | Ireland |
| UK reporting fund status | Yes — on HMRC’s list of reporting funds (list of 02/11/2026); reporting fund since 12/09/2016 |

## Past returns (periods to 13/11/2026)

After the fund's ongoing charges. "Income reinvested" is total return; "price only" leaves out income paid out. Real returns are after UK CPIH inflation.

| Window | Return | After CPIH inflation | Measured as |
|---|---|---|---|
| 1 year | +15.85% | +11.75% | income reinvested |
| 3 years | +62.85% | +47.13% | income reinvested |
| 5 years | +40.38% | +9.57% | income reinvested |

Returns: as reported (delayed data). Inflation: UK CPIH, latest month published.

## Calendar-year returns

Calendar-year returns of iShares Ageing Population UCITS ETF in pounds (price, with income reinvested in the fund): 2022 −3.9%, 2023 +2.8%, 2024 +11.2%, 2025 +16.2%; 2026 to 13/11/2026 +13.2%. Returns of iShares Ageing Population UCITS ETF in pounds (price, with income reinvested in the fund) over the 12 months to 30/09/2026: +15.0%; to 30/09/2025: +15.1%; to 30/09/2024: +14.0%; to 30/09/2023: −2.9%; to 30/09/2022: −4.7%.

| Year | Return | After CPIH inflation | Measured as |
|---|---|---|---|
| 2022 | -3.9% | -12.0% | Price |
| 2023 | +2.8% | -1.3% | Price |
| 2024 | +11.2% | +7.4% | Price |
| 2025 | +16.2% | +12.2% | Price |
| 2026 to 13/11/2026 | +13.2% | +9.6% | Price |

## Risk metrics

| Window | Volatility | Max drawdown |
|---|---|---|
| 1 year | 11.39% | -6.78% |
| 3 years | 12.03% | -14.54% |
| 5 years | 13.29% | -16.41% |

## Largest fall

Volatility of iShares Ageing Population UCITS ETF in pounds, annualised from weekly returns to 13/11/2026: 11.4% over 1 year, 12.0% over 3 years, 13.3% over 5 years. Largest fall in the price of iShares Ageing Population UCITS ETF since November 2021, in pounds: −15.3% from 03/02/2023 to 27/10/2023. The lowest 12-month return of iShares Ageing Population UCITS ETF in pounds (price, with income reinvested in the fund) since January 2021 was −14.8% (12 months to 17/06/2022); the highest was +30.0% (12 months to 17/04/2026). On 13/11/2026 the price of iShares Ageing Population UCITS ETF was 2.0% below its highest weekly close since November 2021 (04/09/2026), in pounds.

## Charges compared with similar funds

Ongoing charge of iShares Ageing Population UCITS ETF 0.40% a year. Compared on 14/11/2026, 7 of the 28 other healthcare funds charge more, 2 the same and 19 less (share classes counted once).

## Charges & eligibility

- Ongoing charges figure (OCF): **0.40%** per year
- Stocks and shares ISA eligible: usually (check with your platform)
- SIPP eligible: usually (check with your provider)
- ISA and SIPP mean the kind of product usually qualifies under HMRC rules. We do not check each platform’s list — each provider decides which funds it offers. Crypto ETNs have not qualified for a stocks and shares ISA since 06/04/2026, and overseas funds that are not UK-recognised UCITS, such as Swiss ETFs, do not usually qualify.

## What it holds

As of 06/11/2026, AGES holds 345 positions, according to its published holdings. The largest is Genmab at 1.03% of the fund; the ten largest make up 7.5%.

### Top holdings

Largest positions (as of 06/11/2026), as a percentage of the whole fund:

| # | Holding | Ticker | Weight |
|---|---|---|---|
| 1 | Genmab | [GMAB](https://fundology.uk/stock/GMAB) | 1.03% |
| 2 | Glaukos | [GKOS](https://fundology.uk/stock/GKOS) | 0.87% |
| 3 | Tenet Healthcare | [THC](https://fundology.uk/stock/THC) | 0.83% |
| 4 | Halozyme Therapeutics | [HALO](https://fundology.uk/stock/HALO) | 0.71% |
| 5 | Regeneron Pharmaceuticals | [REGN](https://fundology.uk/stock/REGN) | 0.71% |
| 6 | PharmaEssentia | [6446](https://fundology.uk/stock/6446) | 0.68% |
| 7 | Fresenius SE | [FRE](https://fundology.uk/stock/FRE) | 0.67% |
| 8 | Labcorp | [LH](https://fundology.uk/stock/LH) | 0.66% |
| 9 | Ramsay Health Care | [RHC](https://fundology.uk/stock/RHC) | 0.65% |
| 10 | Universal Health Services · Class B | [UHS](https://fundology.uk/stock/UHS) | 0.65% |

## Where it invests

Shares of the whole fund. Bonds, cash and positions without a classification are shown as they come, not guessed.

### By sector

As published for the fund, as of 06/11/2026.

| Sector | Weight |
|---|---|
| Health Care | 48.7% |
| Financials | 43.6% |
| Consumer Discretionary | 5.5% |
| Real Estate | 0.7% |
| Consumer Staples | 0.7% |
| Cash and derivatives | 0.4% |
| Materials | 0.2% |
| Communication Services | 0.1% |
| Other sectors | 0.1% |

### By country

As published for the fund, as of 06/11/2026.

| Country | Weight |
|---|---|
| United States | 53.2% |
| Japan | 6.2% |
| United Kingdom | 5.0% |
| Switzerland | 4.0% |
| Australia | 3.9% |
| Canada | 2.8% |
| China | 2.5% |
| France | 2.5% |
| Other countries | 19.7% |

### By type of asset

Added up from the fund’s published holdings, as of 06/11/2026.

| Type of asset | Weight |
|---|---|
| Equity | 99.5% |
| Cash and money market | 0.4% |

The 343 holdings on record (of 345 reported): https://fundology.uk/fund/ages/holdings

## Questions people ask

**What is the ongoing charge of AGES?**

The ongoing charge of AGES is 0.40% a year — about £40 a year on every £10,000 invested, taken from the fund’s value rather than billed to you. Platform and dealing fees are charged separately. Ongoing charge of iShares Ageing Population UCITS ETF 0.40% a year. Compared on 14/11/2026, 7 of the 28 other healthcare funds charge more, 2 the same and 19 less (share classes counted once).

**What does AGES track?**

AGES tracks the STOXX Global Ageing Population Index - USD.

**Is AGES accumulating or distributing?**

AGES is accumulating: income is reinvested inside the fund, so it shows up as a rising price rather than cash paid to you.

**What is the ISIN of AGES?**

The ISIN of AGES is IE00BYZK4669. An ISIN identifies one exact share class of a fund; AGES is its ticker on the London Stock Exchange. The same share class is also listed as AGED (London Stock Exchange, US dollars) and 2B77 (Xetra, euros).

**What does AGES hold?**

As of 06/11/2026, AGES holds 345 positions, according to its published holdings. The largest is Genmab at 1.03% of the fund; the ten largest make up 7.5%. Its ten largest holdings are Genmab (1.03%), Glaukos (0.87%), Tenet Healthcare (0.83%), Halozyme Therapeutics (0.71%), Regeneron Pharmaceuticals (0.71%), PharmaEssentia (0.68%), Fresenius SE (0.67%), Labcorp (0.66%), Ramsay Health Care (0.65%) and Universal Health Services · Class B (0.65%).

**What were AGES’s returns in each of the last five years?**

Calendar-year returns of AGES in pounds (price, with income reinvested in the fund): 2022 −3.9%, 2023 +2.8%, 2024 +11.2%, 2025 +16.2%; 2026 to 13/11/2026 +13.2%. Past performance is not a guide to future returns.

**How has AGES done after inflation?**

Over the five years to 13/11/2026 AGES’s total return was +40.4%, or +9.6% after UK CPIH inflation. Past performance is not a guide to future returns.

## Fund documents

- [Fund page at iShares](https://www.ishares.com/uk/individual/en/products/284218/ishares-ageing-population-ucits-etf)
- [Key investor information document (KIID)](https://www.ishares.com/gls-download/literature/kiid/ucits_kiid-ishares-ageing-population-ucits-etf-usd-acc-gb-ie00byzk4669-en.pdf)
- [Factsheet](https://www.ishares.com/gls-download/literature/fact-sheet/aged-ishares-ageing-population-ucits-etf-fund-fact-sheet-en-gb.pdf)
- Links checked 12/10/2026.

---

We show information. We are not financial advisers, not authorised by the FCA, and never recommend specific investments.

Capital at risk. Past performance is not a guide to future returns. The value of investments can fall as well as rise.